Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Dutasteride × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2 Endocrine 1

Conditions

Multiple Endocrine Neoplasia Type 1 1

Interventions

Specimen Handling 12 Magnetic Resonance Spectroscopy 12 lutetium Lu 177 dotatate 7 gallium Ga 68 dotatate 7 Cisplatin 6 Everolimus 5 pazopanib 4 cabozantinib 4 Etoposide 4 olaparib 3 cixutumumab 3 X-Rays 3 Sunitinib 3 Sorafenib 3 Fluorodeoxyglucose F18 3 tipifarnib 2 belinostat 2 aldesleukin 2 Trastuzumab 2 Topotecan 2 Temozolomide 2 Salts 2 Radiotherapy 2 Phantoms, Imaging 2 Oxaliplatin 2 Octreotide 2 Nivolumab 2 Mitotane 2 Ipilimumab 2 Gefitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00493987 2010-05-13

5aR

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Phase 4 Completed

Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡